Galapagos

On May 8, Galapagos will become Lakefront Biotherapeutics, and our official new LinkedIn page under the new name will become the primary channel for company updates. In connection with the name change, our ticker symbol on Euronext and NASDAQ (ADRs) will change from GLPG to LKFT. We are grateful to the employees, partners, and shareholders who helped shape Galapagos and look forward to carrying that commitment into our next chapter. This Galapagos page will remain live during the transition period for continuity.

Press Release | Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update Galapagos will host a conference call and webcast presentation May 7, 2026, at 14:00 CET / 8:00 am ET. For details, visit our Webcasts section: https://lnkd.in/et2xjKDu Read more in our press release: https://lnkd.in/g6Hy95zK

We're pleased to share that today our shareholders approved our proposal to change our name to Lakefront Biotherapeutics, effective May 8th. Our new name and look and feel are designed to reflect an exciting new chapter for the Company... one in which we continue to evolve and build for the future with a clear sense of purpose and direction. Look for updates on our name change across our channels in the coming weeks! Read more: https://lnkd.in/g8zw2kCB

Press Release | Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases. Galapagos will host a conference call and webcast presentation today, March 31, 2026, at 14:00 CET / 8:00 am ET. The live webcast is accessible via the following link: https://lnkd.in/gYjRpKpa Read more in our press release: https://lnkd.in/g_avZSTT

Press Release | Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings Read more: https://lnkd.in/g8gDAy_e

Press release | Galapagos Appoints Tania Philipp as Chief Human Resources Officer. A seasoned life sciences executive, Ms. Philipp joins Galapagos with a strong track record in change management. Read more:   https://lnkd.in/gFTYRXnY #GLPG #PioneeringForPatients #Leadership

📢 Watch the replay of our full year 2025 earnings conference call for investors and analysts. For details, visit our Webcasts section: https://lnkd.in/et2xjKDu

Press release | Galapagos Reports Full Year 2025 Results and Provides Fourth Quarter Business Update Read more: https://lnkd.in/gUhjTbfi

Press release | Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors. Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board. Read more: https://lnkd.in/g-YpwiMS #GLPG #PioneeringForPatients #Governance

📢 Galapagos to Host Conference Call to Discuss Full Year 2025 Financial Results and Provide Fourth Quarter Business Update on February 23, 2026. For details, visit our Webcasts section: https://lnkd.in/et2xjKDu